Expression of EHZF in hematopoietic and nonhematopoietic cell lines
Cell type . | Cell line . | EHZF . |
|---|---|---|
| Hematopoietic | ||
| Mega/erythroid | K-562 | ++++ |
| HEL | ++++ | |
| Megakaryoblastic | MO7e | - |
| T lymphoid | HPB-ALL | ++ |
| Jurkat | ++ | |
| Molt-4 | ++ | |
| H9 | - | |
| B lymphoid | Raji (pre-B) | ++ |
| IM-9 | - | |
| U266 | - | |
| Daudi (EBV+) | - | |
| Myeloid (immature) | KG-1 | - |
| Myelo-monocytic | HL-60 | - |
| Monocytic | THP-1 | ++ |
| U-937 | - | |
| Natural killer | Nischi | - |
| Nonhematopoietic | ||
| Adenocarcinoma, cervix | HeLa | - |
| Adenocarcinoma, colon | CaCo2 | - |
| Kidney carcinoma | 293 | +++ |
| Bladder carcinoma | 5637 | - |
| Hepatocarcinoma | Hep3B | - |
| Embryonal | P19 | ++ |
Cell type . | Cell line . | EHZF . |
|---|---|---|
| Hematopoietic | ||
| Mega/erythroid | K-562 | ++++ |
| HEL | ++++ | |
| Megakaryoblastic | MO7e | - |
| T lymphoid | HPB-ALL | ++ |
| Jurkat | ++ | |
| Molt-4 | ++ | |
| H9 | - | |
| B lymphoid | Raji (pre-B) | ++ |
| IM-9 | - | |
| U266 | - | |
| Daudi (EBV+) | - | |
| Myeloid (immature) | KG-1 | - |
| Myelo-monocytic | HL-60 | - |
| Monocytic | THP-1 | ++ |
| U-937 | - | |
| Natural killer | Nischi | - |
| Nonhematopoietic | ||
| Adenocarcinoma, cervix | HeLa | - |
| Adenocarcinoma, colon | CaCo2 | - |
| Kidney carcinoma | 293 | +++ |
| Bladder carcinoma | 5637 | - |
| Hepatocarcinoma | Hep3B | - |
| Embryonal | P19 | ++ |
Amounts of EHZF mRNA were assessed by Northern blotting and by RT-PCR with specific primers using cDNA derived from 100 ng RNA. The quantity of product is indicated, when undetectable after 40 cycles of PCR as (-); when low (+), moderate (++), high (+++), or abundant (++++).